Skip to main content
. 2026 Feb 3;16(2):186. doi: 10.3390/brainsci16020186
ANCOVA analyses of covariance
AVH auditory verbal hallucinations
BACS Brief Assessment of Cognition in Schizophrenia
CDSS Calgary Depression Scale for Schizophrenia total score 
CGI Clinical Global Impression
CIAS Cognitive Impairment Associated with Schizophrenia
DLPFC Dorsolateral Prefrontal Cortex 
EEG Electroencephalography
FGAs first-generation antipsychotics
GABA γ-Aminobutyric acid
LAI Long Acting Injectable
LTD long-term depression
LTP long-term potentiationNIBS—Non-Invasive Brain Stimulation
NMDA N-methyl-D-aspartate
NS Negative symptoms
NoSM Non-Smoker patients
PANSS Positive and Negative Symptoms Scale
PLWS people living with schizophrenia
RCT randomized controlled trial
rTMS repetitive transcranial Magnetic Stimulation
SGAs second-generation antipsychotics
SM Smoker patients
T timepoint
tDCS transcranial Direct Current Stimulation